Patient selection and administration of aeroallergen vaccines

Immunotherapy often is used as a treatment fur allergic diseases such as al lergic rhinitis and asthma. The acceptance of immunotherapy for treating al lergic rhinitis or asthma has been previously limited by the historical lac k of adequate numbers of double-blind, placebo-controlled trials of specifi c allergen immunotherapy involving Large numbers of patients. Nonetheless, numerous studies have shown that immunotherapy for allergic respiratory dis eases significantly reduces the severity of symptoms and medication require ments. Criteria can help in selecting patients in whom immunotherapy will b e beneficial with minimal risks.